Borros Arneth | Pharmacology | Best Researcher Award

Published on 14/07/202514/07/2025 by Top Pharmaceutical

Borros Arneth | Pharmacology | Best Researcher Award

Dr. Borros Arneth at Justus Liebig University Giessen and Philipps University Marburg Germany, Germany.

Dr. Borros Michael Arneth (born August 5, 1973) is a distinguished German physician and laboratory medicine expert 🧪. He studied medicine, chemistry, and biochemistry at Goethe University Frankfurt and earned his Dr. med. with research on HIV via MR spectroscopy 🧠. With board certification in Laboratory Medicine and EurClinChem recognition, he has held leading roles at TU Dresden and Giessen-Marburg University Hospital 🏥. His expertise spans neonatal screening, hematology, and molecular diagnostics 🧫. Dr. Arneth is also an editor and reviewer for top journals 📚 and a recipient of prestigious scholarships like Studienstiftung des Deutschen Volkes.

Publication Profile

Google Scholar

Education

Dr. Borros Arneth, born on August 5, 1973, in Bad Homburg, has cultivated a remarkable academic and professional career in medicine 🧬 and chemistry ⚗️. He pursued dual studies at Johann Wolfgang Goethe University, earning his Dr. med. with a focus on HIV diagnostics via MR spectroscopy 🧠. Recognized as a European Specialist in Clinical Chemistry and Laboratory Medicine (EurClinChem) 🇪🇺, he advanced through intensive training in Frankfurt, Mainz, and Dresden. His professional scope includes neonatal screening 👶🧪, hematology 🩸, and molecular diagnostics 🔬, making him a leading voice in laboratory medicine and biomedical innovation.

Teaching Contributions

Dr. Borros Arneth has made impactful teaching contributions at Universitätsklinikum Giessen Marburg, where he serves as head of key sections 🧬🩸, including hematology, neonatal screening 👶, and molecular diagnostics 🔬. As a dedicated university lecturer (Lehrbeauftragter) 👨‍🏫, Dr. Arneth plays a vital role in shaping the future of clinical laboratory medicine. His passion for academic mentorship 🌟 and knowledge transfer has guided numerous medical students and young professionals toward excellence. Through his integrated teaching and clinical responsibilities, he continues to inspire innovation, ethical practice, and critical thinking in the next generation of laboratory physicians.

Research Focus

Dr. Borros Arneth’s research expertise spans clinical biochemistry, immunology, and neurological disorders, with a strong emphasis on the tumor microenvironment 🧫, multiple sclerosis 🧠, and biomarker discovery in autoimmune and psychiatric diseases 🧬. His notable work includes investigations into liquid biopsies 💉, CYP2D6 pharmacogenomics 💊, and gut-brain axis communication 🌱➡️🧠. Additionally, he explores trained innate immunity 🛡️, diabetes metabolomics 🍭, and light chain analysis in CSF for CNS diseases. Through interdisciplinary integration, Dr. Arneth advances precision diagnostics and translational medicine for complex chronic and neurological conditions.

Publication Top Notes

Minjian Chen | Pharmacodynamics | Best Researcher Award

Published on 03/05/202503/05/2025 by Top Pharmaceutical

Minjian Chen | Pharmacodynamics | Best Researcher Award

Prof. Dr. Minjian Chen, Nanjing Medical University, China

Prof. Dr. Minjian Chen is a distinguished toxicologist and professor at Nanjing Medical University. He earned his Ph.D. in Toxicology (2013) and has led pioneering research on male infertility and birth defects using metabolomics and exposomics. He has completed over 10 major research projects, including NSFC and China’s National Key R&D programs, and holds 4 national patents. Recognized in Jiangsu’s “Qinglan Project,” he has international experience, including research at the U.S. NIEHS. With an H-index of 36, Prof. Chen is a rising leader in environmental health science and precision diagnostics.

Publication Profile

Scopus

Education

Prof. Dr. Minjian Chen 🎓 earned his Bachelor’s degree in Preventive Medicine (2003–2008) and Ph.D. in Toxicology (2008–2013) from Nanjing Medical University (NMU). He completed postdoctoral training (2013–2018) at NMU’s School of Basic Medicine and was selected for the China–Australia Young Scientist Exchange Program in 2014 🌏. From 2019 to 2020, he served as a guest researcher at the U.S. National Institute of Environmental Health Sciences (NIEHS), NIH 🧪. Appointed as a Lecturer in 2013 and promoted to Professor in 2023 at NMU, he is honored as an Outstanding Young Backbone Teacher under Jiangsu’s “Qinglan Project” and a Distinguished Young Academic Leader 🌟.

Professional Memberships

Prof. Dr. Minjian Chen 🧑‍🔬 holds several prominent positions in the scientific community. He serves as the Vice Secretary-General of the Evidence-based Toxicology Professional Committee with the Chinese Society of Toxicology ⚖️. As an Executive Member of the Third Youth Committee of the same society, he actively contributes to advancing toxicology research. He is also a member of the Fertility Preservation and Restoration Professional Committee with the China Association of Obstetrics and Gynecology 👶. Additionally, he is part of multiple professional committees, including the Mutagenesis Professional Committee and the Jiangsu Provincial Preventive Medicine Association 🌱. He is the Vice Chair of the Youth Committee for the Jiangsu Provincial Society of Toxicology.

Research Focus

Prof. Dr. Minjian Chen’s research primarily focuses on metabolomics and environmental toxicology, investigating how chemical exposures disrupt metabolic processes, especially during critical developmental stages. His work includes examining the effects of substances like PFOS (perfluorooctane sulfonate) on embryonic development, exploring metabolic changes in oocyte growth, and understanding spermatogenesis in mice. Dr. Chen also studies pharmacology by analyzing the urate-lowering effects of compounds like delphinidin-3-glucoside. His integrated approach to omics technologies provides insights into how environmental chemicals alter metabolism, offering potential clinical implications. His contributions are crucial for advancing ecotoxicology, metabolic disorders, and biochemical research.

Publication Top Notes

Metabolic characterizations of PFOS-induced disruptions in early embryonic development

Association of Personal Care and Consumer Product Chemicals with Long-Term Amenorrhea: Insights into Serum Globulin and STAT3

Characterization of Metabolic Patterns in Mouse Spermatogenesis and Its Clinical Implications in Humans

Multi-Omics Reveal the Metabolic Changes in Cumulus Cells During Aging

Urate-lowering effect of delphinidin-3-glucoside in red kidney beans via binding to the FAD site of the XO enzyme

Integrative Omics Reveals the Metabolic Patterns During Oocyte Growth

The global phosphorylation landscape of mouse oocytes during meiotic maturation

Environmental Chemical Exposomics and Metabolomics in Toxicology: The Latest Updates

Characterization of metabolic patterns in porcine cumulus cells during meiotic maturation

Exposure to Molybdate Results in Metabolic Disorder: An Integrated Study of the Urine Elementome and Serum Metabolome in Mice

Roxana Matran | Pharmacology | Best Researcher Award

Published on 23/01/202523/01/2025 by Top Pharmaceutical

Roxana Matran | Pharmacology | Best Researcher Award

Assist Prof Dr Roxana Matran, UMF “Carol Davila”, Romania

Dr. Roxana Matran is a distinguished pediatric gastroenterologist and academic with a Ph.D. from Carol Davila University of Medicine and Pharmacy (2017) 🎓. An Assistant Professor at the same university since 2019, she excels in teaching and research on pediatric pulmonology and gastroenterology. Her clinical expertise at “Grigore Alexandrescu” Emergency Hospital for Children includes contributions to groundbreaking clinical trials on inflammatory bowel diseases 🏥🔬. A dedicated volunteer with MD Caravana cu Medici 🤝, she brings healthcare to underserved communities. Dr. Matran’s active membership in ESPGHAN and advisory roles showcase her impactful influence in public health policy 🌍✨.

Publication Profile

orcid

Educational Backgrounds

Assist. Prof. Dr. Roxana Matran embarked on her academic journey at the prestigious Central School in Bucharest, where she specialized in Mathematics-Informatics with bilingual French instruction (📘✏️). She continued her education at “Carol Davila” University of Medicine and Pharmacy, earning a Bachelor’s Degree in 2009 (🎓🩺). Driven by her passion for medicine, she pursued a Ph.D. at the same university, completing her thesis on factors contributing to pulmonary disease in cystic fibrosis between 2013 and 2017 (📄🫁). Her dedication and expertise in the medical field have solidified her reputation as a leading academic and researcher in Bucharest (🌟🏥).

Work Experiance

Assist. Prof. Dr. Roxana Matran is a distinguished pediatric gastroenterologist and academic based in Bucharest. She serves as a member of the Advisory Committee on Post-Vaccination Adverse Reactions, analyzing vaccine-related health concerns (💉📊). She is also a sub-investigator in pivotal clinical trials, including studies on Vedolizumab and Adalimumab for pediatric Crohn’s disease and ulcerative colitis (🔬📑). Dr. Matran volunteers with Caravana cu Medici, offering medical consultations in underserved Romanian villages (🚑🤝). As an Assistant Professor at “Carol Davila” University, she teaches fifth-year medical students and conducts extensive research (📚👩‍🔬). Her work at “Grigore Alexandrescu” Emergency Hospital focuses on consultations, rounds, and clinical studies (🏥👶).

Membership

Assist. Prof. Dr. Roxana Matran is an active member of esteemed professional organizations in her field. Since June 2019, she has been a Full Member of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN), contributing to advancements in pediatric healthcare across Europe (🌍👶🩺). Additionally, she has been a dedicated member of the Romanian Society of Pediatrics since July 2016, working to promote excellence in pediatric medicine and research in her home country (🇷🇴📚💉). Her involvement in these societies underscores her commitment to improving children’s health and staying at the forefront of medical advancements (🌟🔬).

Conference and Seminars

Assist. Prof. Dr. Roxana Matran has an extensive track record of participation in prestigious medical events and specialized training programs worldwide. In 2024, she is set to attend the 5th Liver Transplant School in Brussels (25–28 September) and the ESPGHAN Mastercourse in Parenteral Nutrition in Linz, Austria (4–6 March). Her prior engagements include the ESPGHAN IBD Masterclass in Helsinki, Finland (2022) and the International Symposium on Pediatric Inflammatory Bowel Disease in Edinburgh, Scotland (2022). Over the years, she has honed her expertise in pediatric gastroenterology, nutrition, and pulmonology, attending courses in Italy 🇮🇹, Austria 🇦🇹, France 🇫🇷, and Greece 🇬🇷, and even completing a post-graduate program online 🌐.

Community Impact

Assist. Prof. Dr. Roxana Matran is deeply committed to serving underserved communities, demonstrating her passion for equitable healthcare access. She actively volunteers with MD Caravana cu Medici, a noble initiative providing essential medical consultations in impoverished Romanian villages 🏡. Through this work, Dr. Matran brings her expertise in pediatric gastroenterology and nutrition to those who need it most, offering care, guidance, and hope 🌟. Her dedication to improving public health goes beyond the clinic, reflecting a strong sense of compassion and responsibility toward marginalized populations 🤝. Dr. Matran’s efforts exemplify the true spirit of community service and medical care ❤️.

Clinical Expertise

Assist. Prof. Dr. Roxana Matran has made significant contributions to pediatric gastroenterology through her clinical practice, research, and involvement in clinical trials. As a pediatric gastroenterologist at “Grigore Alexandrescu” Emergency Hospital for Children 🏥, she seamlessly combines patient care with groundbreaking research. Dr. Matran has actively contributed as a subinvestigator for leading pharmaceutical companies, including Takeda Pharmaceuticals (VedolizumabSC-3003) and AbbVie (Adalimumab), advancing therapies for pediatric inflammatory bowel disease 🔬. She also researches post-vaccination adverse reactions as a member of the Advisory Committee at the Ministry of Health, ensuring better health outcomes for children globally 💉.

Research Focus

Dr. Roxana Elena Smădeanu’s research focus primarily revolves around pediatric health, with a special emphasis on diagnosing and managing complex diseases such as cystic fibrosis, intestinal tuberculosis, and respiratory conditions in children. Her work includes exploring microbiota’s role in functional abdominal pain disorders, respiratory symptomatology associated with COVID-19 in pediatric patients, and rare genetic syndromes like Menke-Hennekam syndrome. Additionally, her research delves into diagnostic methods like sweat conductivity in cystic fibrosis. This body of work aligns with clinical and laboratory research aimed at improving pediatric healthcare and diagnostics. 🧑‍🔬🩺👶

Publication Top Notes

Anti-Tumor Necrosis Factor-α Use in Pediatric Inflammatory Bowel Disease—Reports from a Romanian Center

Anti TNF-a Use in Pediatric Inflammatory Bowel Disease – Reports from a Romanian Center

Quality of Life of Pediatric Patients with Chronic Intestinal, Liver, and Pancreatic Diseases During the COVID-19 Pandemic

Menke–Hennekam Syndrome: A Literature Review and a New Case Report